Avellino Launches AvaGen Nationwide as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophies

Avellino Lab USA, Inc. (Avellino) today announced full nationwide availability in the U.S. of AvaGen, The Genetic Eye Test, as the first genetic test that helps determine a patients risk of keratoconus and the presence of other corneal dystrophies.